J. Andersson
Impact in
- Oncology top 5%
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in ⓘ
- Oncology 5
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
- Cancer-related Molecular Pathways 1
-
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- M. Lindqvist (1 shared paper)G Fagerberg (1 shared paper)Nils Bjurstam (1 shared paper)Stig Wall (1 shared paper)L. E. Rutqvist (1 shared paper)A. Lindgren (1 shared paper)L. Tabár (1 shared paper)Jan Frisell (1 shared paper)
- Journals
- Acta Oncologica (2 papers)Applied immunohistochemistry & molecular morphology (1 paper)Journal of Pediatric Gastroenterology and Nutrition (1 paper)The Lancet (1 paper)Annals of Oncology (1 paper)
- Partner nations
- Sweden
In The Last Decade
J. Andersson
7 papers receiving 804 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 688
- Cancer Research 250
- Pathology and Forensic Medicine 112
- Radiology, Nuclear Medicine and Imaging 92
- Genetics 90
Countries citing papers authored by J. Andersson
This map shows the geographic impact of J. Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Andersson more than expected).
Fields of papers citing papers by J. Andersson
This network shows the impact of papers produced by J. Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Andersson. The network helps show where J. Andersson may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Andersson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Breast cancer screening with mammography: overview of Swedish randomised trials Hit paper breakdown → | 1993 | 707 |
| 2 | 2005 | 46 | |
| 3 | 2003 | 41 | |
| 4 | 2004 | 35 | |
| 5 | Deep venous thrombosis treated with a standard dosage of streptokinase. | 1970 | 13 |
| 6 | 2000 | 12 | |
| 7 | 2002 | 11 | |
| 8 | 1998 | 1 |
About J. Andersson
J. Andersson is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Dermatology, having authored 8 papers that have together received 866 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Treatment and Pharmacology (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Cancer-related Molecular Pathways (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Oncology (688 citations), Cancer Research (250 citations), Pathology and Forensic Medicine (112 citations), Radiology, Nuclear Medicine and Imaging (92 citations) and Genetics (90 citations). J. Andersson has collaborated with scholars based in Sweden. Frequent co-authors include M. Lindqvist, G Fagerberg, Nils Bjurstam, Stig Wall, L. E. Rutqvist, A. Lindgren, L. Tabár, Jan Frisell, Lars‐Gunnar Larsson and L. Nyström. Their work appears in journals such as Acta Oncologica, Applied immunohistochemistry & molecular morphology, Journal of Pediatric Gastroenterology and Nutrition, The Lancet and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.